Compounds > reboxetine
Page last updated: 2024-09-03

reboxetine and Drug Withdrawal Symptoms

reboxetine has been researched along with Drug Withdrawal Symptoms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Alen, F; Arco, R; Ballesta, A; Decara, J; Gómez de Heras, R; Orio, L; Pavón, FJ; Ramírez-López, M; Rodríguez de Fonseca, F; Serrano, A; Suárez, J; Vadas, E; Vargas, A1
Brunner, H; Friess, E; Pollmächer, T; Wichniak, A1
Bowers, R; Cox, D; McBride, A1
di Giannantonio, M; Farina, B1
Alamo, C; Blasco-Fontecilla, H; de Pablo, S; González-Parra, S; López-Muñoz, F; Molina, JD1

Other Studies

5 other study(ies) available for reboxetine and Drug Withdrawal Symptoms

ArticleYear
Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking.
    Addiction biology, 2021, Volume: 26, Issue:3

    Topics: Alcoholism; Animals; Drug-Seeking Behavior; Endocannabinoids; Glutamic Acid; Hippocampus; Male; Prefrontal Cortex; Rats; Rats, Wistar; Reboxetine; Self Administration; Signal Transduction; Substance Withdrawal Syndrome

2021
Successful suppression of cataplectic attacks with tramadol.
    Neurology, 2003, Sep-23, Volume: 61, Issue:6

    Topics: Aged; Biogenic Monoamines; Cataplexy; Female; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Morpholines; Narcotics; Reboxetine; Receptors, Opioid; Recurrence; Sleep, REM; Substance Withdrawal Syndrome; Tramadol; Tranylcypromine; Treatment Outcome

2003
Reboxetine may be helpful in the treatment of amphetamine withdrawal.
    British journal of clinical pharmacology, 2004, Volume: 58, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Amphetamine-Related Disorders; Humans; Morpholines; Reboxetine; Substance Withdrawal Syndrome

2004
Reboxetine in cocaine withdrawal treatment: a three cases report.
    Drug and alcohol review, 2003, Volume: 22, Issue:3

    Topics: Adult; Antidepressive Agents; Cocaine; Humans; Male; Morpholines; Reboxetine; Substance Withdrawal Syndrome

2003
Monotherapy with reboxetine in amphetamine withdrawal syndrome.
    Progress in neuro-psychopharmacology & biological psychiatry, 2006, Sep-30, Volume: 30, Issue:7

    Topics: Amphetamine-Related Disorders; Antidepressive Agents; Female; Humans; Middle Aged; Morpholines; Reboxetine; Substance Withdrawal Syndrome

2006